147 related articles for article (PubMed ID: 38297074)
1. Mass spectrometry in IgG4-related disease diagnosis.
Onwuka DC; Chen LYC; Zhan SH; Seidman MA; Cartagena L; Killow V; Abou-Tak H; Mattman A; Carruthers MN
Sci Rep; 2024 Jan; 14(1):2584. PubMed ID: 38297074
[TBL] [Abstract][Full Text] [Related]
2. Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS/MS.
van der Gugten G; DeMarco ML; Chen LYC; Chin A; Carruthers M; Holmes DT; Mattman A
Clin Chem; 2018 Apr; 64(4):735-742. PubMed ID: 29352044
[TBL] [Abstract][Full Text] [Related]
3. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease.
Della-Torre E; Lanzillotta M; Germanò T; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L
Semin Arthritis Rheum; 2021 Aug; 51(4):761-765. PubMed ID: 34144386
[TBL] [Abstract][Full Text] [Related]
4. The Significance of Serum IgG4/IgG and IgG4/IgG1 Ratio in the Diagnosis Value of IgG4-Related Diseases.
Wang W; Li Y; Feng H
Discov Med; 2023 Aug; 35(177):476-482. PubMed ID: 37553301
[TBL] [Abstract][Full Text] [Related]
5. The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China.
Liu Z; Nie Y; Peng Y; Lu H; Zhang P; Li J; Sun R; Li J; Sun B; He X; Zhou J; Fei Y; Peng L; Zhang W; Zeng X
Semin Arthritis Rheum; 2023 Aug; 61():152202. PubMed ID: 37167774
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of
Bai Z; Zhou T; Yu Z; Chen Y; Dong L
Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of IgG Subclasses in Serum Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
van der Gugten JG; Holmes DT; Mattman A
Methods Mol Biol; 2022; 2546():205-216. PubMed ID: 36127591
[TBL] [Abstract][Full Text] [Related]
8. Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease.
Kogami M; Abe Y; Ando T; Makiyama A; Yamaji K; Tamura N
Sci Rep; 2023 Feb; 13(1):2509. PubMed ID: 36782006
[TBL] [Abstract][Full Text] [Related]
9. Roles of IgG4 and IgG4/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level.
Wang H; Wang C; Wan Q; Li L
Clin Rheumatol; 2023 Mar; 42(3):793-800. PubMed ID: 36305979
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Classification Criteria Performance in a Single-Center Cohort of 114 Patients With Immunoglobulin G4-Related Disease.
Spandorfer R; Ahmad M; Khosroshahi A
J Clin Rheumatol; 2023 Jan; 29(1):23-28. PubMed ID: 35905474
[TBL] [Abstract][Full Text] [Related]
11. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice.
Mizushima I; Yamano T; Kawahara H; Hibino S; Nishioka R; Zoshima T; Hara S; Ito K; Fujii H; Nomura H; Kawano M
Rheumatology (Oxford); 2021 Jul; 60(7):3317-3325. PubMed ID: 33313857
[TBL] [Abstract][Full Text] [Related]
12. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
13. Distribution characteristics of elevated serum immunoglobulin G
Yang H; Li J; Wang Y; Ye S; Li J
Scand J Rheumatol; 2019 Nov; 48(6):497-504. PubMed ID: 31354076
[No Abstract] [Full Text] [Related]
14. Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry.
Ladwig PM; Barnidge DR; Snyder MR; Katzmann JA; Murray DL
Clin Chem; 2014 Aug; 60(8):1080-8. PubMed ID: 24799527
[TBL] [Abstract][Full Text] [Related]
15. Rosai-Dorfman disease mimicking IgG4-related diseases: a single-center experience in China.
Wang L; Li W; Zhang S; Peng L; Shen M; Song S; Zhang W; Cao X; Feng R; Zhang W
Orphanet J Rare Dis; 2020 Oct; 15(1):285. PubMed ID: 33054782
[TBL] [Abstract][Full Text] [Related]
16. Increased Circulating Th1 and Tfh1 Cell Numbers Are Associated with Disease Activity in Glucocorticoid-Treated Patients with IgG4-Related Disease.
Xia C; Liu C; Liu Y; Long Y; Xu L; Liu C
J Immunol Res; 2020; 2020():3757015. PubMed ID: 33313326
[TBL] [Abstract][Full Text] [Related]
17. Radiology domain in the diagnosis of IgG4-RD according to the 2019 American College of Rheumatology and European League Against Rheumatism classification.
Elbanna KY; Kowa JY; Mirajkar N; Khalili K; Kim TK
Insights Imaging; 2024 Mar; 15(1):94. PubMed ID: 38530483
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS based plasma metabolomics and lipidomics reveal alterations associated with IgG4-related disease.
Gong Y; Zhang P; Liu Z; Li J; Lu H; Wang Y; Qiu B; Wang M; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Zhang W
Rheumatology (Oxford); 2021 Jul; 60(7):3252-3261. PubMed ID: 33341881
[TBL] [Abstract][Full Text] [Related]
19. Cut-off values of serum IgG4 among three reagents, including a novel IgG4 reagent: a multicenter study.
Usami Y; Sugano M; Uehara T; Koinuma M; Ishimine N; Kawasaki K; Yamauchi K; Hamano H; Honda T
Sci Rep; 2021 Mar; 11(1):7280. PubMed ID: 33790306
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]